Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.135
+0.015 (0.36%)
Aug 10, 2026, 10:05 AM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $232.4 million as of August 10, 2026. Its market cap has increased by 92.45% in one year.
Market Cap
232.40M
Enterprise Value
58.03M
1-Year Change
92.45%
Ranking
Category
Stock Price
$4.14
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $232.40M, an increase of 34.21%. That is a compound annual growth rate of 4.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 232.40M | -18.63% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 241.49M |
| Niagen Bioscience | 241.05M |
| Pyxis Oncology | 234.42M |
| AC Immune | 233.12M |
| Galectin Therapeutics | 225.89M |
| Compugen | 224.50M |
| Camp4 Therapeutics | 224.32M |
| Keros Therapeutics | 216.02M |